Prithviraj Bose Selected Research

Prithviraj Bose Research Topics

Disease

42	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 03/2016
38	Neoplasms (Cancer) 01/2024 - 11/2009
25	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 07/2014
16	Anemia 04/2024 - 12/2016
14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2023 - 11/2016
11	Cytopenia 06/2023 - 06/2017
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 01/2016
10	Splenomegaly 11/2023 - 12/2016
9	Systemic Mastocytosis 06/2023 - 01/2018
9	Leukemia 01/2021 - 11/2009
8	Polycythemia Vera 01/2024 - 12/2016
8	Thrombocytopenia (Thrombopenia) 01/2023 - 05/2017
7	Essential Thrombocythemia 01/2024 - 12/2016
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2022 - 11/2009
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 07/2014
6	Multiple Myeloma 01/2018 - 01/2013
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
4	Thrombocytosis (Thrombocythemia) 11/2023 - 01/2017
4	Philadelphia Chromosome 01/2020 - 01/2017
3	Invasive Fungal Infections 03/2024 - 04/2011
3	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 06/2012
3	Thrombosis (Thrombus) 11/2023 - 12/2016
3	Infections 11/2023 - 01/2020
3	Pleural Effusion (Pleural Effusions) 11/2022 - 01/2018
3	Fibrosis (Cirrhosis) 01/2022 - 07/2018
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 11/2014
2	Leukocytosis (Pleocytosis) 11/2023 - 01/2019
2	Disease Progression 06/2023 - 03/2016
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 01/2019
2	Eosinophilia 01/2021 - 01/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 01/2018
2	Inflammation (Inflammations) 08/2019 - 01/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 11/2014
2	Lymphoma (Lymphomas) 06/2017 - 11/2014
2	Hemorrhage 02/2017 - 12/2016
2	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2009
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2014 - 11/2014
1	Herpes Zoster 03/2024
1	Histoplasmosis 03/2024
1	Opportunistic Infections (Opportunistic Infection) 03/2024
1	Nausea 11/2023

Drug/Important Bio-Agent (IBA)

34	ruxolitinibIBA 03/2024 - 03/2016
14	venetoclaxIBA 05/2023 - 01/2017
13	Janus KinasesIBA 03/2024 - 03/2016
13	Janus Kinase InhibitorsIBA 03/2024 - 12/2016
7	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 10/2023 - 06/2017
7	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 06/2023 - 06/2017
7	ibrutinibIBA 12/2021 - 11/2016
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
6	Activin Receptors (Activin Receptor)IBA 10/2023 - 12/2016
6	LigandsIBA 11/2021 - 12/2016
6	Bortezomib (Velcade)FDA Link 01/2021 - 06/2009
5	fedratinibIBA 03/2024 - 01/2019
5	InterferonsIBA 01/2024 - 12/2016
5	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 01/2016
5	Hemoglobins (Hemoglobin)IBA 06/2023 - 01/2017
5	avapritinibIBA 06/2023 - 01/2019
5	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2018
5	alvocidib (flavopiridol)IBA 01/2018 - 06/2012
4	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 09/2015
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 11/2016
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 12/2016
4	Decitabine FDA Link 01/2021 - 01/2020
3	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2023 - 01/2017
3	Dasatinib (BMS 354825)FDA Link 11/2022 - 01/2018
3	Rituximab (Mabthera)FDA Link 12/2021 - 11/2014
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2019
3	midostaurinIBA 11/2019 - 01/2018
3	Vorinostat FDA Link 01/2019 - 01/2016
3	Janus Kinase 1IBA 01/2019 - 12/2016
3	Histone Deacetylase InhibitorsIBA 01/2018 - 12/2016
3	Apoptosis Regulatory ProteinsIBA 01/2017 - 09/2014
2	ACE-011IBA 04/2024 - 01/2017
2	CytokinesIBA 01/2024 - 01/2023
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2023 - 01/2018
2	HepcidinsIBA 10/2023 - 01/2022
2	RNA Splicing FactorsIBA 06/2023 - 01/2022
2	Histones (Histone)IBA 01/2023 - 09/2014
2	Reticulin (Reticular Fiber)IBA 01/2022 - 10/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2016
2	imetelstatIBA 01/2022 - 01/2017
2	isavuconazoleIBA 01/2021 - 10/2018
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021 - 01/2020
2	givinostatIBA 06/2020 - 01/2017
2	CateninsIBA 01/2020 - 01/2019
2	bcr-abl Fusion ProteinsIBA 01/2020 - 11/2009
2	Brentuximab VedotinIBA 01/2019 - 12/2014
2	Janus Kinase 2IBA 01/2019 - 06/2017
2	Lysine (L-Lysine)FDA Link 12/2018 - 09/2014
2	Proteasome InhibitorsIBA 01/2018 - 11/2014
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018 - 09/2015
2	PRM-151IBA 01/2018 - 01/2017
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 09/2015
2	Antifibrotic AgentsIBA 12/2016 - 12/2016
2	Imatinib Mesylate (Gleevec)FDA Link 06/2012 - 11/2009
1	Interferon-alpha (Interferon Alfa)IBA 11/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023

Therapy/Procedure

49	Therapeutics 03/2024 - 11/2009
16	Drug Therapy (Chemotherapy) 11/2023 - 01/2015
4	Drug Tapering 01/2020 - 01/2018